Developments for the Oil and Gas sector
We are one of the few companies in Brazil that have expertise in offering biotechnological solutions for the Oil and Gas sector. We develop projects for the evaluation and remediation of biocorrosion caused by sulfate-reducing bacteria (SRB). The company has almost a decade of experience and great expertise for detection, characterization and control of bacteria involved in biocorrosion in different matrices, such as oil and process water.
Research and Development
With roots at the Federal University of Viçosa, research and development are part of Microbiotec’s DNA. The team of researchers developed some impactful solutions, such as antigens for Dengue virus, Chikungunya and Sars-Cov-2. Antigen and vaccine development are high technology services that Microbiotec offers, as well, with technology transfer.
Heterologous protein expression technology
Arabidopsis thaliana
Rendimento:
203 mg/kg
203.000 testes
37 plantas
1 kg
Antígenos
Sars-cov-2
Arbovírus
NS1
Prokaryote
Yeasts
Mammal Cel
Plants
Specificity
IGM
IGG
56%
59%
99%
65%
Gold standard
91%
87%
Sensitivity
IGM
IGG
88%
90%
87%
87%
Gold standard
84%
83%
Performance
Low
Low
Low
High
Cost
Low
Average
High
Low
Arabidopsis thaliana
Yield:
203 mg/kg
203,000 tests
37 plants
1 kg
Antigens
Sars-cov-2
Arbovirus
Antigen Panel
Immunogenic Protein
Protein secreted in early stages of infection
B
PC
SARS-COV-2 S protein
DENV3 PRM/E protein
DENV1 NS1 protein
DENV2 NS1 protein
DENV3 NS1 protein
DENV4 NS1 protein
ZIKA NS1 protein
B2B
B2B2C
Timeline Desenvolvimento Antígenos
Detecção dos vírus dengue em macerados de larvas Aedes aegypti R$ 19.832,00 CNPq
Produção de antígenos para testes diagnósticos R$ 42.840,00 FAPEMIG
Expressão da proteína NS1 da dengue em plantas R$39.600,00 CNPQ
Triagem da potencial atividade anti-dengue R$ 32.067,00 FAPEMIG
Expressão do vírus dengue-1e-3 pra diagnóstico rápido R$ 29.600,00 CNPQ
Estudo da fisiopatogenia da dengue e dengue hemorrágica R$ 54.000,00 CNPQ
Expressão heteróloga da proteína NS1 do vírus dengue-2 R$ 59.220,00 FAPEMIG
Produção de quimeras vacinais contra o vírus SARS-CoV-2 R$ 478.728,32 CNPq
SARS-CoV-2 Virus-like particles (VLPs) para de kits diagnósticos sorológicos de baixo custo R$ 40.757,00 UFV
Produção de quimeras vacinais contra o vírus SARS-CoV-2 R$ 464.712,00 CNPq
-
Av. Oraida Mendes de Castro, 6000 Novo Silvestre -
36576-400 - Viçosa/MG - (21) 98175-7232
- contato@microbiotec.bio
Spearheaded by:
Developed by the company:
